Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.02
0.04 (3.96%)
At close: Aug 15, 2025, 2:36 PM

Lucid Diagnostics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
22.36M 18.9M 22.47M 53.66M
Short-Term Investments
n/a n/a 1.33M 1.12M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
1.13M 1.13M 1.11M 725K
Receivables
405K 45K 17K 200K
Inventory
341K 278K 111K 493K
Other Current Assets
n/a 1.98M n/a n/a
Total Current Assets
25.15M 22.07M 24.36M 57.3M
Property-Plant & Equipment
3.7M 2.64M 3.6M 971K
Goodwill & Intangibles
736K 1.42M 3.44M n/a
Total Long-Term Assets
5.57M 5.2M 8.15M 1.7M
Total Assets
30.71M 27.27M 32.51M 59M
Account Payables
1.24M 1.15M 1.06M 1.49M
Deferred Revenue
n/a 936K n/a n/a
Short-Term Debt
18.6M 13.95M 962K n/a
Other Current Liabilities
1.35M 791K 4.57M 2.21M
Total Current Liabilities
23.52M 29.38M 8.43M 4.26M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
1.8M 199K 1.04M 1.49M
Total Liabilities
25.32M 29.58M 9.46M 4.26M
Total Debt
21.25M 15.26M 2M n/a
Common Stock
63K 42K 41K 35K
Retained Earnings
-203.77M -150.74M -98.08M -41.9M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
5.39M -2.31M 23.05M 54.74M
Total Investments
n/a n/a 1.33M 1.12M